United States· US:68071-2202_1d75dc5e-3f67-d0c3-e063-6294a90aac2b

Fluocinonide

A fluocinonide product containing fluocinonide, registered in United States by NuCare Pharmaceuticals,Inc.. The same ATC class is registered in 6 of our 19 countries.

ATC D07AC08US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedFluocinonideATCD07AC08REGISTER NO.US:68071-2202_1d75dc5…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Fluocinonide is registered in 6 of 19 countries.

Countries holding a registration under ATC D07AC08 (fluocinonide), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 3 of them publish a price we can compare per daily dose

Fluocinonide · ATC D07AC08

6 / 19 countries

  • Canada
  • Finlandprice
  • Germany
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
FLUOCINONIDE
Manufacturer
NuCare Pharmaceuticals,Inc.
Country
United States (US)
ATC code
D07AC08
ATC class
Fluocinonide
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    68071-2202-5
  • ndc11
    6807122025
    1 TUBE in 1 CARTON (68071-2202-5) / 15 g in 1 TUBE

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

141 interactions on record for fluocinonide.

Graded by severity as the source publishes them — 55 minor. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Fluocinonide · interactions on record

141 records

  • 55 minor
  • 86 info

Most severe, free to view

    Mechanism and what to do, in the interaction check
    Interaction register. Grades as the source publishes them.

    Same medicine, other countries

    Fluocinonide in 5 other countries

    What each register calls a product with the same active substance — salts and hydrates count as the same.

    All fluocinonide products

    Authorised across Europe · EMA

    The same active substance is authorised in 5 EEA countries. Names it is sold under:

    • Germany · Topsym, Topsym-F
    • Spain · Novoter
    • United Kingdom (Northern Ireland) · Metosyn, Metosyn Fapg
    • Greece · Lidex
    • Italy · Topsyn

    Source: European Medicines Agency, Article 57 product data.

    Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

    For developers

    The same record over the API, and the raw payload
    GET /v1/drugs/6e2ba088-c9a8-401d-8f7c-2830059ded7f
    GET /v1/drugs/6e2ba088-c9a8-401d-8f7c-2830059ded7f?format=fhir

    Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

    {
      "route": "TOPICAL",
      "source": "ndc",
      "strength": ".5",
      "substance": "FLUOCINONIDE",
      "productndc": "68071-2202",
      "dosage_form": "OINTMENT",
      "dea_schedule": null,
      "strength_unit": "mg/g",
      "application_number": "ANDA073481",
      "marketing_category": "ANDA"
    }

    See everything about fluocinonide.

    This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.